Ajai Nemani, MD
Interventional Pain Medicine · Naples, FLNPI 1649265539
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.6%), consulting fees and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Spinal Simplicity, LLC at 53.9% of the total. Reporting peaked in 2023 at $12,072 and has fallen 95.4% since, to $561 in 2025.
Across 218 payments — averaging $118.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$14K
- Abbott$3K
- Omnia Medical, LLC$3K
- Boston Scientific$2K
- Nevro Corp.$2K
- Collegium Pharmaceutical, Inc.$375
- plus $1K from 11 others
What the payments were for
- Consulting fees$7,85030%
- Travel & lodging$3,66414%
- Food & beverage$8,18932%
- Education$6,19024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 18 | $13,950 |
| Abbott | 83 | $3,434 |
| Omnia Medical, LLC | 1 | $3,100 |
| Boston Scientific | 35 | $2,278 |
| Nevro Corp. | 24 | $1,532 |
| Collegium Pharmaceutical, Inc. | 22 | $375 |
| Vertos Medical, Inc. | 15 | $347 |
| Medtronic | 6 | $266 |
| Nalu Medical, Inc. | 1 | $146 |
| Saluda Medical Americas, Inc. | 3 | $144 |
| Curonix LLC | 3 | $94 |
| Stimwave Technologies Incorporated | 1 | $81 |
| SPR Therapeutics, Inc | 2 | $70 |
| Globus Medical | 1 | $27 |
| Pfizer | 1 | $17 |
| Si-bone, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,893 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 11 | $6,180 |
| Morphine Sulfate ErMorphine Sulfate | 56 | $3,428 |
| Gabapentin | 56 | $1,184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $564 |
| Tramadol Hcl | 45 | $444 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $433 |
| Pregabalin | 13 | $151 |
| Trazodone Hcl | 13 | $124 |
| Meloxicam | 29 | $110 |
| Duloxetine Hcl | 13 | $109 |
| Naproxen | 11 | $88 |
| Baclofen | 12 | $83 |
| Cyclobenzaprine Hcl | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $375 | $6,18011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Naples
- Ivan SamcamNaples$51K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.